跳至主要内容
临床试验/NCT00561808
NCT00561808已完成不适用

In-Vitro Maturation of Oocytes From Polycystic Ovarian Patients Undergoing IVF

Hillel Yaffe Medical Center2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2008年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
Maturation rate of oocytes, their fertilization rate, cleavage rate and embryo quality.

研究概览

简要总结

Retrieval of immature oocytes from women with polycystic ovaries, their in-vitro maturation, fertilization and embryo transfer can prevent hormonal treatment that can lead to ovarian hyperstimulation. In addition, it can decrease discomfort and side-effects of routine daily administration of hormones and it can be cost-effective. Thirty healthy women with Polycystic Ovarian Syndrome aged 20-35, with BMI 18-30 kg/msq will be included in the study. Their immature oocytes will be retrieved from small follicles without any hormonal treatment. The oocytes will be fertilized post in-vitro maturation. The developed embryros will be transferred to the patients as in a routine IVF cycle.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy women diagnosed with Polycystic Ovarian Syndrome with BMI 18-30 kg/sqm, aged 20-35

排除标准

  • Every one else

结局指标

主要结局

Maturation rate of oocytes, their fertilization rate, cleavage rate and embryo quality.

时间窗: one year

次要结局

  • Implantation rate and successful delivery.(one year)

研究者

申办方类型
Other Gov

研究点 (2)

Loading locations...

相似试验